Sky Valley Advisors was founded by Edward Tsai in 2017. We work with clinical-stage biotech executives and boards on functions that would otherwise require a larger team across strategy, finance, capital advisory, and operations.
Management consultant specializing in advanced biotechnology and technology companies.
Advised boards and executive leaders across technology and drug development, from translational and pre-clinical research through clinical and commercial-stage companies. Primarily focused in oncology, neurology, and cell therapies such as CAR-T and iPSC-based regenerative medicine.
Sky Valley is small by design. For most engagements, that's enough. When a deeper bench is helpful, we bring in trusted specialists.
Corporate finance specialist with a diverse array of expertise, including biotech/healthcare ECM investment banking in NYC and deep experience in financial modeling, pitch decks, and valuations across private and public capital transactions. Participated in the execution of 100+ deals across multiple sectors.
When an engagement requires deeper expertise, we bring in IP attorneys, regulatory consultants, principal investigators, corporate counsel, and other specialists from a long-standing network. We coordinate the work so clients see one integrated team.
A 30-minute intro call is the fastest way to see if there's a fit.
Book a 30-minute intro